Benzimidazole carboxamides as raf kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/12 (2006.01) A61K 31/4439 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01) C07D 403/12 (2006.01)

Patent

CA 2531856

The present invention relates to benzimidazole carboxamides of formula (I), the use of the compounds of formula (I) as inhibitors of as inhibitors of one or more kinases, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient. Accordingly, the compound of Formula (I) or a pharmaceutically acceptable salt thereof is administered for the treatment of diseases mediated by one or more kinase phathways, preferably by the raf kinase pathway, especially cancers.

L'invention concerne des benzimidazole carboxamides de formule (I), l'utilisation desdits composés de formule (I) en tant qu'inhibiteurs d'une ou plusieurs kinases, l'utilisation des composés de formule (I) pour la fabrication d'une composition pharmaceutique et un procédé de traitement, comprenant l'administration de ladite composition pharmaceutique à un patient. Selon l'invention, le composé de formule (I) ou un de ses sels pharmaceutiquement acceptables est administré pour traiter des maladies médiées par une ou plusieurs voies de kinases, de préférence par la voie de la kinase raf, en particulier des cancers.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Benzimidazole carboxamides as raf kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole carboxamides as raf kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole carboxamides as raf kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1405795

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.